Quick search
Advanced search in
Field to searchTerm
Add rule
Filters (5)
Download Results
260 research outcomes, page 1 of 26
  • publication . Article . 2022
    Open Access English
    Authors:
    Mehdi Stiti; Guilaume Castanet; Andrew Corber; Marcus Alden; Edouard Berrocal;
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | Spray-Imaging (638546)

    To control the evolution of a pandemic such as COVID-19, knowing the conditions under which the pathogen is being transmitted represents a critical issue, especially when implementing protection strategies like social distancing and face masks wearing. For viruses and b...

    Add to ORCIDorcid
  • publication . Article . Preprint . 2021
    Open Access English
    Authors:
    Laura Di Domenico; Giulia Pullano; Chiara E. Sabbatini; Pierre-Yves Boëlle; Vittoria Colizza;
    Publisher: Nature Publishing Group UK
    Project: ANR | DataRedux (ANR-19-CE46-0008), EC | MOOD (874850), ANR | SPHINx (ANR-17-CE36-0008)

    As countries in Europe implement strategies to control the COVID-19 pandemic, different options are chosen regarding schools. Through a stochastic age-structured transmission model calibrated to the observed epidemic in Île-de-France in the first wave, we explored scena...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Daniel Sanchez-Guzman; Sonja Boland; Oliver Brookes; Claire Mc Cord; René Lai Kuen; Valentina Sirri; Armelle Baeza Squiban; Stéphanie Devineau;
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | BIORIMA (760928)

    AbstractThe human bronchial epithelium is the first line of defense against atmospheric particles, pollutants, and respiratory pathogens such as the novel SARS-CoV-2. The epithelial cells form a tight barrier and secrete proteins that are major components of the mucosal...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Samuele Bovo; Giuseppina Schiavo; Anisa Ribani; Valerio Joe Utzeri; Valeria Taurisano; Mohamad Ballan; María Muñoz; Estefania Alves; J. P. Araujo; Riccardo Bozzi; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | TREASURE (634476)

    AbstractCoronaviruses silently circulate in human and animal populations, causing mild to severe diseases. Therefore, livestock are important components of a “One Health” perspective aimed to control these viral infections. However, at present there is no example that c...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Benjamin Gaborit; Bernard Vanhove; Marie-Anne Vibet; Aurélie Le Thuaut; Karine Lacombe; Vincent Dubee; Florence Ader; Virginie Ferre; Eric Vicaut; Jéremie Orain; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | BRIGHT (962036)

    Abstract Background Early inhibition of entry and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a very promising therapeutic approach. Polyclonal neutralizing antibodies offers many advantages such as providing immediate immunity, co...

    Add to ORCIDorcid
  • research data . 2021
    Open Access English
    Authors:
    Mondino, Elena; Di Baldassarre, Giuliano; Mård, Johanna; Ridolfi, Elena; Rusca, Maria; Raffetti, Elena; Del Giudice, Emanuele; Scolobig, Anna;
    Publisher: Zenodo
    Project: EC | HydroSocialExtremes (771678)

    This dataset is the result of nation-wide surveys conducted in Italy and Sweden between August 5th and August 19th 2020. The survey explores the respondents' risk perception, preparedness, knowledge, and experience regarding a set of hazards, namely: epidemics, floo...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Min‐Wen Ku; Pierre Authié; Maryline Bourgine; François Anna; Amandine Noirat; Fanny Moncoq; Benjamin Vesin; Fabien Nevo; Jodie Lopez; Philippe Souque; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | PASTEURDOC (665807)

    International audience; COVID-19 vaccines already in use or in clinical development may have reduced efficacy against emerging SARS-CoV-2 variants. In addition, although the neurotropism of SARS-CoV-2 is well established, the vaccine strategies currently developed have ...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Christoph Kessel; Richard Vollenberg; Katja Masjosthusmann; Claas Hinze; Helmut Wittkowski; France Debaugnies; Carole Nagant; Francis Corazza; Frédéric Vély; Gilles Kaplanski; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | ImmunAID (779295)

    Abstract Objectives Infection with the novel coronavirus SARS‐CoV‐2 triggers severe illness with high mortality in a subgroup of patients. Such critical course of coronavirus disease (COVID)‐19 is thought to associate with cytokine storm as in macrophage activation synd...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Ostaszewski, Marek; Niarakis, Anna; Mazein, Alexander; Kuperstein, Inna; Phair, Robert; Orta-Resendiz, Aurelio; Singh, Vidisha; Aghamiri, Sara,; Acencio, Marcio,; Glaab, Enrico; ...
    Publisher: HAL CCSD
    Project: EC | INFORE (825070), EC | iPLACENTA (765274), EC | PerMedCoE (951773)

    We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort t...

    Add to ORCIDorcid
  • publication . Preprint . Research . 2021
    Open Access English
    Authors:
    Sandrine Belouzard; Arnaud Machelart; Valentin Sencio; Thibaut Vausselin; Eik Hoffmann; Nathalie Deboosere; Yves Rouillé; Lowiese Desmarets; Karin Séron; Adeline Danneels; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Project: EC | INTRACELLTB (260901)

    AbstractThe fastest way to implement a treatment against a new rapidly emerging viral disease consists in screening the potential antiviral activity of drugs approved for human use. This has the advantage of shortening regulatory preclinical development steps. Here, we ...

    Add to ORCIDorcid
260 research outcomes, page 1 of 26